Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rafii

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Neurology and Therapy|March 8, 2026
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderJonathan D Santoro, Saba Jafarpour, Panteha Hayati Rezvan, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [<sup>18</sup>F]-Fluoroethoxybenzovesamicol Positron Emission Tomography ImagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Annals of Clinical and Translational Neurology|June 8, 2026
Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression DisorderJonathan D Santoro, Mackenzie Silverman, Maeve C Lucas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 16, 2022
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's diseaseMichael S Rafii, Reisa A Sperling, Michael C Donohue, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's DiseaseZ Shirzadi, A P Schultz, M Properzi, et al.
Journal of Neurology|June 22, 2024
De novo variants in immune regulatory genes in Down syndrome regression disorderSaba Jafarpour, Abhik K Banerjee, Mellad M Khoshnood, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 2, 2020
The AT(N) framework for Alzheimer's disease in adults with Down syndromeMichael S Rafii, Beau M Ances, Nicole Schupf, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 14, 2014
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's diseaseMichael S Rafii, Tiffany L Baumann, Roy A E Bakay, et al.
Journal of Neurodevelopmental Disorders|June 6, 2022
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorderJonathan D Santoro, Rebecca Partridge, Runi Tanna, et al.
Nature Medicine|November 2, 2001
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthD Lyden, K Hattori, S Dias, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Neurology and Therapy|March 8, 2026
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderJonathan D Santoro, Saba Jafarpour, Panteha Hayati Rezvan, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [<sup>18</sup>F]-Fluoroethoxybenzovesamicol Positron Emission Tomography ImagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Annals of Clinical and Translational Neurology|June 8, 2026
Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression DisorderJonathan D Santoro, Mackenzie Silverman, Maeve C Lucas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 16, 2022
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's diseaseMichael S Rafii, Reisa A Sperling, Michael C Donohue, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's DiseaseZ Shirzadi, A P Schultz, M Properzi, et al.
Journal of Neurology|June 22, 2024
De novo variants in immune regulatory genes in Down syndrome regression disorderSaba Jafarpour, Abhik K Banerjee, Mellad M Khoshnood, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 2, 2020
The AT(N) framework for Alzheimer's disease in adults with Down syndromeMichael S Rafii, Beau M Ances, Nicole Schupf, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 14, 2014
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's diseaseMichael S Rafii, Tiffany L Baumann, Roy A E Bakay, et al.
Journal of Neurodevelopmental Disorders|June 6, 2022
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorderJonathan D Santoro, Rebecca Partridge, Runi Tanna, et al.
Nature Medicine|November 2, 2001
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthD Lyden, K Hattori, S Dias, et al.
Pageof 22